Literature DB >> 23108393

Sgk1 enhances RANBP1 transcript levels and decreases taxol sensitivity in RKO colon carcinoma cells.

R Amato1, D Scumaci, L D'Antona, R Iuliano, M Menniti, M Di Sanzo, M C Faniello, E Colao, P Malatesta, A Zingone, V Agosti, F S Costanzo, A M Mileo, M G Paggi, F Lang, G Cuda, P Lavia, N Perrotti.   

Abstract

The serum- and glucocorticoid-regulated kinase (Sgk1) is essential for hormonal regulation of epithelial sodium channel-mediated sodium transport and is involved in the transduction of growth factor-dependent cell survival and proliferation signals. Growing evidence now points to Sgk1 as a key element in the development and/or progression of human cancer. To gain insight into the mechanisms through which Sgk1 regulates cell proliferation, we adopted a proteomic approach to identify up- or downregulated proteins after Sgk1-specific RNA silencing. Among several proteins, the abundance of which was found to be up- or downregulated upon Sgk1 silencing, we focused our attention of RAN-binding protein 1 (RANBP1), a major effector of the GTPase RAN. We report that Sgk1-dependent regulation of RANBP1 has functional consequences on both mitotic microtubule activity and taxol sensitivity of cancer cells.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23108393     DOI: 10.1038/onc.2012.470

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  26 in total

1.  Cytoplasmic translocation of MTA1 coregulator promotes de-repression of SGK1 transcription in hypoxic cancer cells.

Authors:  H Marzook; S Deivendran; B George; G Reshmi; T R Santhoshkumar; R Kumar; M R Pillai
Journal:  Oncogene       Date:  2017-05-15       Impact factor: 9.867

2.  Ras-ling with new therapeutic targets for metastasis.

Authors:  Joshua A Mason; Zachary T Schafer
Journal:  Small GTPases       Date:  2017-05-04

3.  RanBP1 governs spindle assembly by defining mitotic Ran-GTP production.

Authors:  Michael Shaofei Zhang; Alexei Arnaoutov; Mary Dasso
Journal:  Dev Cell       Date:  2014-11-24       Impact factor: 12.270

4.  Eight-plex iTRAQ labeling and quantitative proteomic analysis for human bladder cancer.

Authors:  Qimin Zhang; Shengsong Huang; Huarong Luo; Xin Zhao; Gang Wu; Denglong Wu
Journal:  Am J Cancer Res       Date:  2017-04-01       Impact factor: 6.166

Review 5.  SGK1: The Dark Side of PI3K Signaling.

Authors:  Antonio Di Cristofano
Journal:  Curr Top Dev Biol       Date:  2016-12-15       Impact factor: 4.897

6.  High expression of Ran binding protein 1 predicts poor outcomes in hepatocellular carcinoma patients: a Cancer Genome Atlas database analysis.

Authors:  Zhengxiao Wei; Xiaoqiong Duan; Qi Li; Qingfeng Li; Yu Wang
Journal:  J Gastrointest Oncol       Date:  2021-12

7.  Identification, structure modification, and characterization of potential small-molecule SGK3 inhibitors with novel scaffolds.

Authors:  Grace Qun Gong; Ke Wang; Xin-Chuan Dai; Yan Zhou; Rajesh Basnet; Yi Chen; De-Hua Yang; Woo-Jeong Lee; Christina Maree Buchanan; Jack Urquhart Flanagan; Peter Robin Shepherd; Ying Chen; Ming-Wei Wang
Journal:  Acta Pharmacol Sin       Date:  2018-07-23       Impact factor: 6.150

8.  Predicting Ovarian Cancer Patients' Clinical Response to Platinum-Based Chemotherapy by Their Tumor Proteomic Signatures.

Authors:  Kun-Hsing Yu; Douglas A Levine; Hui Zhang; Daniel W Chan; Zhen Zhang; Michael Snyder
Journal:  J Proteome Res       Date:  2016-07-08       Impact factor: 4.466

9.  Targeting serum glucocorticoid-regulated kinase-1 in squamous cell carcinoma of the head and neck: a novel modality of local control.

Authors:  Henrik O Berdel; Hongyu Yin; Jun Yao Liu; Karolina Grochowska; Christopher Middleton; Nathan Yanasak; Rafik Abdelsayed; Wolfgang E Berdel; Mahmood Mozaffari; Jack C Yu; Babak Baban
Journal:  PLoS One       Date:  2014-12-08       Impact factor: 3.240

10.  Sex Difference of Egfr Expression and Molecular Pathway in the Liver: Impact on Drug Design and Cancer Treatments?

Authors:  Lishi Wang; Jianqi Xiao; Weikuan Gu; Hong Chen
Journal:  J Cancer       Date:  2016-03-20       Impact factor: 4.207

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.